Back
Avadel Pharmaceuticals PLC Stock Predictions

Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
47
AVDL
Avadel Pharmaceuticals PLC
Last Price:
$9.01
Seasonality Move:
5.62%
7 Day Trial
ALL ACCESS PASS
$
7

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.Avadel Pharmaceuticals PLC Stock Forecast
-
Over the next 52 weeks, Avadel Pharmaceuticals PLC has on average historically risen by 41.7% based on the past 28 years of stock performance.
-
Avadel Pharmaceuticals PLC has risen higher in 13 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 46.43%
-
Is Avadel Pharmaceuticals PLC Stock Undervalued?The current Avadel Pharmaceuticals PLC [AVDL] share price is $9.01. The Score for AVDL is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
AVDL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Avadel Pharmaceuticals PLC Stock Go Up Next Year?
-
Over the next 52 weeks, Avadel Pharmaceuticals PLC has on average historically risen by 41.7% based on the past 28 years of stock performance.
Avadel Pharmaceuticals PLC Stock Rating
Sell
47
Avadel Pharmaceuticals PLC (AVDL)
is a Sell
Is Avadel Pharmaceuticals PLC overpriced?
-
Avadel Pharmaceuticals PLC has risen higher in 13 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 46.43%
Avadel Pharmaceuticals PLC Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Ireland
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
avadel.com
52-Week Data
52-Week High:
17.30
52-Week Low:
6.38
Prediction Charts
Market Cap:
871.6M
Price in USD:
9.01
Volume:
1.1M
Beta:
1.09
Technical Analysis
SMA50:
8.27
SMA100:
8.52
SMA200:
11.06
52-Wk Change:
-43.48%
Stock Predictions
-
Is Avadel Pharmaceuticals PLC stock public?Yes, Avadel Pharmaceuticals PLC is a publicly traded company.
-
What is the Avadel Pharmaceuticals PLC stock quote today?The Avadel Pharmaceuticals PLC stock price is 9.01 USD today.
-
How to buy Avadel Pharmaceuticals PLC stock online?You can buy Avadel Pharmaceuticals PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-29 | 8.71 | 8.61 | 8.90 | 8.60 |
Apr-30 | 8.55 | 8.90 | 8.96 | 8.51 |
May-1 | 8.85 | 8.61 | 8.85 | 8.59 |
May-2 | 8.80 | 8.70 | 8.95 | 8.66 |
May-5 | 8.75 | 9.04 | 9.18 | 8.69 |
May-6 | 8.99 | 8.64 | 9.88 | 8.55 |
May-7 | 9.75 | 9.47 | 9.98 | 8.84 |
May-8 | 9.68 | 9.39 | 9.77 | 8.99 |
May-9 | 9.47 | 9.39 | 9.67 | 9.32 |
May-12 | 9.48 | 9.59 | 9.62 | 9.14 |
May-13 | 9.68 | 9.03 | 9.69 | 8.87 |
May-14 | 9.05 | 8.53 | 9.25 | 8.44 |
May-15 | 8.61 | 8.87 | 8.90 | 8.51 |
May-16 | 8.81 | 9.01 | 9.02 | 8.69 |
Avadel Pharmaceuticals PLC Earnings
Avadel Pharmaceuticals PLC Earnings Report: Per Share Avadel Pharmaceuticals PLC Earnings Q1 Q2 Q3 and Q4 last year and next year.
Avadel Pharmaceuticals PLC Forecast Revenue Growth
Avadel Pharmaceuticals PLC Stock Analysis: Historical quarterly revenues per share for Avadel Pharmaceuticals PLC and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.00 per share, an increase this year of $0.68 per share, and an increase next year of $0.55 per share.
* Avadel Pharmaceuticals PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.